Proteomics: a poweful tool to deepen the molecular mechanisms of ischemic stroke

Currently, the diagnosis relies on neurological assessment of the patient and neuroimaging techniques. A clinical goal for decades has been the identification of biomarkers of impending stroke in asymptomatic subjects and clinical prognosis in stroke patients. One of the potential of the proteomics is to detect novel drug targets and diagnostic markers, useful for disease detection, in easily obtained body fluids, like plasma or urine.